gabexate has been researched along with Dental Caries in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Dental Caries: Localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kudo, T | 1 |
| Chang, HL | 1 |
| Maeda, S | 1 |
| Uchida, Y | 1 |
| Nakamae, J | 1 |
| Inoki, R | 1 |
1 other study available for gabexate and Dental Caries
| Article | Year |
|---|---|
Changes of the Met-enkephalin-like peptide content induced by noxious stimuli in the rat incisor pulp.
Topics: Animals; Captopril; Cycloheximide; Dental Caries; Dental Pulp; Dogs; Enkephalin, Methionine; Esters; | 1983 |